Harbor Investment Advisory’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-250
Closed -$2.13K 1413
2024
Q1
$2.13K Hold
250
﹤0.01% 1092
2023
Q4
$2.1K Hold
250
﹤0.01% 1040
2023
Q3
$2.52K Hold
250
﹤0.01% 1013
2023
Q2
$3.21K Hold
250
﹤0.01% 1177
2023
Q1
$2.31K Hold
250
﹤0.01% 1204
2022
Q4
$2.67K Hold
250
﹤0.01% 1178
2022
Q3
$1K Hold
250
﹤0.01% 1297
2022
Q2
$2K Hold
250
﹤0.01% 1251
2022
Q1
$2K Hold
250
﹤0.01% 1262
2021
Q4
$3K Hold
250
﹤0.01% 1199
2021
Q3
$4K Sell
250
-250
-50% -$3.81K ﹤0.01% 1180
2021
Q2
$8K Hold
500
﹤0.01% 1051
2021
Q1
$10K Buy
500
+250
+100% +$6K ﹤0.01% 992
2020
Q4
$5K Buy
+250
New +$4.6K ﹤0.01% 1023

Other funds holding PROF

Harbor Investment Advisory's PROF Position: Q2 2024 in Review

Harbor Investment Advisory sold out of Profound Medical (PROF) in Q2 2024, closing a stake of 250 shares — an estimated $2.13K sold.

Harbor Investment Advisory first reported a position in PROF in Q4 2020 and held it in 14 quarters. The position peaked at $10K in Q1 2021. 39 funds tracked by Wall St. Rank hold PROF as of Q2 2024.

  • Harbor Investment Advisory reported no remaining Profound Medical position as of Q2 2024 after selling out during the quarter.
  • Harbor Investment Advisory sold 250 Profound Medical shares in Q2 2024, an estimated $2.13K.
  • Harbor Investment Advisory first reported a position in Profound Medical in Q4 2020 and held it in 14 quarters.
  • Harbor Investment Advisory's Profound Medical position peaked at $10K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Profound Medical as of Q2 2024.

Based on Harbor Investment Advisory's 13F filing for Q2 2024, filed 19 Jul 2024.